Jeanny Aragon-Ching, MD
Medical Oncology · Falls Church, VANPI 1376701946
Payments from drug & device makers
Across 1,287 payments — averaging $7270.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$6.4M
- Bayer$817K
- Seagen Inc.$686K
- E.r. Squibb & Sons, L.L.C.$588K
- Pfizer$352K
- Janssen Research & Development, LLC$226K
- plus $285K from 17 others
Across 2 payments — averaging $635.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 505 | $6,402,457 |
| Bayer | 479 | $816,572 |
| Seagen Inc. | 48 | $686,338 |
| E.r. Squibb & Sons, L.L.C. | 47 | $588,109 |
| Pfizer | 30 | $352,139 |
| Janssen Research & Development, LLC | 60 | $226,082 |
| Exelixis Inc. | 24 | $78,706 |
| EMD Serono, Inc. | 36 | $62,241 |
| Macrogenics, Inc. | 13 | $29,460 |
| Astellas Pharma Global Development | 8 | $28,516 |
| Genentech, Inc. | 1 | $28,500 |
| Astellas Pharma US Inc | 15 | $15,729 |
| Merck Kgaa | 2 | $11,040 |
| Sanofi | 4 | $5,673 |
| Novartis | 3 | $5,094 |
| Myovant Sciences Inc. | 1 | $4,650 |
| Amgen | 1 | $3,570 |
| Immunomedics, Inc. | 1 | $2,475 |
| AstraZeneca | 1 | $2,398 |
| Eisai Inc. | 1 | $2,280 |
| AVEO Pharmaceuticals, Inc. | 2 | $2,185 |
| F. Hoffmann-la Roche AG | 4 | $1,772 |
| Janssen Scientific Affairs, LLC | 1 | $758 |
How this compares
$9,356,742 in reported general payments places this provider in the 95th percentile of 95 medical oncology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Falls Church
- Shakuntala MalikFalls Church$503K
- Alexander SpiraFairfax$69.5M
- Ryan GentzlerCharlottesville$5.6M
- Robert DreicerCharlottesville$5.4M
- Kathleen HarndenFairfax$4M
- Matthew ReilleyCharlottesville$3.8M
- Patrick DillonCharlottesville$2.6M
- Varinder KaurCharlottesville$2.4M
- Adam CohenFairfax$2.2M
- Janakiraman SubramanianFairfax$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.